The Enterprise Value as of December 2024 (TTM) for Indivior PLC (INVVY) is 1.50B

According to Indivior PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 1.50B. This represents a change of -28.41% compared to the average of 2.09B of the last 4 quarters.

Indivior PLC (INVVY) Historical Enterprise Value (quarterly & annually)

How has INVVY Enterprise Value performed in the past?

The mean historical Enterprise Value of Indivior PLC over the last ten years is 441.64M. The current 1.50B Enterprise Value has changed 33.79% with respect to the historical average. Over the past ten years (40 quarters), INVVY's Enterprise Value was at its highest in in the June 2023 quarter at 2.98B. The Enterprise Value was at its lowest in in the December 2021 quarter at -329720135.85.

Indivior PLC (INVVY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Indivior PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Indivior PLC (INVVY) Average Enterprise Value

How has INVVY Enterprise Value performed in the past?

The current Enterprise Value of Indivior PLC (INVVY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Indivior PLC (INVVY) Enterprise Value vs. Peers

How is INVVY’s Enterprise Value compared to its peers?

Indivior PLC’s Enterprise Value is greater than Orexo AB (publ) (1.08B), less than Genomma Lab Internacional, S.A.B. de C.V. (27.96B), less than Hypera S.A. (19.33B), less than Sumitomo Pharma Co., Ltd. (515.96B), less than Elanco Animal Health Incorporated (9.70B), greater than SIGA Technologies, Inc. (330.41M), greater than Esperion Therapeutics, Inc. (570.53M), less than Catalent, Inc. (16.13B), less than Neurocrine Biosciences, Inc. (13.78B), less than Amphastar Pharmaceuticals, Inc. (2.27B), less than Collegium Pharmaceutical, Inc. (1.77B), greater than Ironwood Pharmaceuticals, Inc. (1.27B), less than ANI Pharmaceuticals, Inc. (1.61B), greater than Alpha Teknova, Inc. (489.28M), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than Lifecore Biomedical, Inc. (407.91M), greater than Organogenesis Holdings Inc. (414.39M), greater than Petros Pharmaceuticals, Inc. (6.23M), greater than Pacira BioSciences, Inc. (1.29B), less than Intra-Cellular Therapies, Inc. (8.61B), less than Alkermes plc (4.74B), greater than Eagle Pharmaceuticals, Inc. (19.21M),

Build a custom stock screener for Indivior PLC (INVVY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Indivior PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Indivior PLC (INVVY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Indivior PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.